Duprat, F.; Robles, C.; Castillo, M.P.; Rivas, Y.; Mondaca, M.; Jara, N.; Roa, F.; Bertinat, R.; Toledo, J.; Paz, C.;
et al. LOX-1 Activation by oxLDL Induces AR and AR-V7 Expression via NF-κB and STAT3 Signaling Pathways Reducing Enzalutamide Cytotoxic Effects. Int. J. Mol. Sci. 2023, 24, 5082.
https://doi.org/10.3390/ijms24065082
AMA Style
Duprat F, Robles C, Castillo MP, Rivas Y, Mondaca M, Jara N, Roa F, Bertinat R, Toledo J, Paz C,
et al. LOX-1 Activation by oxLDL Induces AR and AR-V7 Expression via NF-κB and STAT3 Signaling Pathways Reducing Enzalutamide Cytotoxic Effects. International Journal of Molecular Sciences. 2023; 24(6):5082.
https://doi.org/10.3390/ijms24065082
Chicago/Turabian Style
Duprat, Felix, Catalina Robles, MarÃa Paz Castillo, Yerko Rivas, Marcela Mondaca, Nery Jara, Francisco Roa, Romina Bertinat, Jorge Toledo, Cristian Paz,
and et al. 2023. "LOX-1 Activation by oxLDL Induces AR and AR-V7 Expression via NF-κB and STAT3 Signaling Pathways Reducing Enzalutamide Cytotoxic Effects" International Journal of Molecular Sciences 24, no. 6: 5082.
https://doi.org/10.3390/ijms24065082
APA Style
Duprat, F., Robles, C., Castillo, M. P., Rivas, Y., Mondaca, M., Jara, N., Roa, F., Bertinat, R., Toledo, J., Paz, C., & González-ChavarrÃa, I.
(2023). LOX-1 Activation by oxLDL Induces AR and AR-V7 Expression via NF-κB and STAT3 Signaling Pathways Reducing Enzalutamide Cytotoxic Effects. International Journal of Molecular Sciences, 24(6), 5082.
https://doi.org/10.3390/ijms24065082
